Zealand Pharma Updates Share Buyback Program for Week 35, 2026

The Danish biopharmaceutical firm disclosed transaction data related to its share repurchase initiative for the third week of August 2026. The report highlights continued efforts to manage equity dilution and return value to shareholders.